Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies
Autor: | Lukas Smolej, Pavlína Králíčková, Monika Motyčková, Jan Krejsek, Pavel Zak, Eva Malá, Ondrej Soucek, Vojtěch Thon, Martin Simkovic, J. Kuhnova, Pavel Vodárek, Ctirad Andrys |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Male
Immunoglobulin levels 0302 clinical medicine Immunology and Allergy Medicine Immunodeficiency chemistry.chemical_classification Aged 80 and over biology Healthy population General Medicine Middle Aged Prognosis Antibodies Bacterial 3. Good health Streptococcus pneumoniae 030220 oncology & carcinogenesis Female Antibody Research Article lcsh:Immunologic diseases. Allergy Adult Article Subject Adolescent Immunology Alpha (ethology) Galactosylceramides Polysaccharide Pneumococcal Infections 03 medical and health sciences Young Adult Humans In patient Bacterial Capsules Aged Autoantibodies business.industry Common variable immunodeficiency medicine.disease Immunity Humoral Immunoglobulin A Common Variable Immunodeficiency chemistry Immunoglobulin M Immunoglobulin G biology.protein business lcsh:RC581-607 Biomarkers 030215 immunology |
Zdroj: | Journal of Immunology Research Journal of Immunology Research, Vol 2017 (2017) |
ISSN: | 2314-7156 2314-8861 |
Popis: | Humoral deficiencies represent a broad group of disorders. The aim of the study was to compare the levels of antibodies against pneumococcal capsular polysaccharides (anti-PCP) and natural anti-galactosyl (anti-Gal) antibodies in (1) patients with chronic lymphocytic leukaemia (CLL), (2) patients with common variable immunodeficiency (CVID), and (3) a healthy population and to explore their diagnostic and prognostic potential. Serum immunoglobulin levels and levels of anti-Gal IgG, IgA, and IgM and anti-PCP IgG and IgG2 were determined in 59 CLL patients, 30 CVID patients, and 67 healthy controls. Levels of IgG, IgA, IgM, anti-Gal IgA, anti-Gal IgM, and anti-PCP IgA were lower in CLL and CVID patients than in healthy controls (p value for all parameters |
Databáze: | OpenAIRE |
Externí odkaz: |